Joel Greenblatt's BSX Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 201,112 shares of Boston Scientific Corporation (BSX) worth $19.63 M, representing 0.09% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Joel Greenblatt has maintained a long-term strategic position in BSX, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2017, adding 1.56 M shares. Largest reduction occurred in Q2 2017, reducing 1.64 M shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Boston Scientific Corporation (BSX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Boston Scientific Corporation (BSX) Trades by Joel Greenblatt
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +60,895 | Add 0.00% | 60,894 | $9.26 |
| Q3 2013 | -42,150 | Reduce 69.22% | 18,744 | $11.74 |
| Q4 2013 | -18,744 | Sold Out | 18,744 | $0.00 |
| Q4 2016 | +99,384 | New Buy | 99,384 | $21.63 |
| Q1 2017 | +1.56 M | Add 1574.40% | 1.66 M | $24.87 |
| Q2 2017 | -1.64 M | Reduce 98.52% | 24,597 | $27.73 |
| Q3 2017 | +4,046 | Add 16.45% | 28,643 | $29.19 |
| Q4 2017 | +475,026 | Add 1658.44% | 503,669 | $24.79 |
| Q1 2018 | -503,669 | Sold Out | 503,669 | $0.00 |
| Q2 2018 | +59,660 | New Buy | 59,660 | $32.70 |
| Q3 2018 | -49,745 | Reduce 83.38% | 9,915 | $38.53 |
| Q4 2018 | -71 | Reduce 0.72% | 9,844 | $35.35 |
| Q1 2019 | +10,099 | Add 102.59% | 19,943 | $38.36 |
| Q2 2019 | -19,943 | Sold Out | 19,943 | $0.00 |
| Q1 2020 | +23,468 | New Buy | 23,468 | $32.64 |
| Q2 2020 | -1,543 | Reduce 6.57% | 21,925 | $35.12 |
| Q3 2020 | -12,215 | Reduce 55.71% | 9,710 | $38.21 |
| Q4 2020 | -2,161 | Reduce 22.26% | 7,549 | $35.90 |
| Q1 2021 | +6,116 | Add 81.02% | 13,665 | $38.64 |
| Q2 2021 | -2,156 | Reduce 15.78% | 11,509 | $42.75 |
| Q3 2021 | +95,930 | Add 833.52% | 107,439 | $43.39 |
| Q4 2021 | -100,854 | Reduce 93.87% | 6,585 | $42.52 |
| Q1 2022 | +2,108 | Add 32.01% | 8,693 | $44.29 |
| Q2 2022 | -8,693 | Sold Out | 8,693 | $0.00 |
| Q1 2023 | +4,044 | New Buy | 4,044 | $50.03 |
| Q2 2023 | +20,650 | Add 510.63% | 24,694 | $54.09 |
| Q3 2023 | -20,535 | Reduce 83.16% | 4,159 | $52.80 |
| Q4 2023 | +849 | Add 20.41% | 5,008 | $57.81 |
| Q1 2024 | +1,338 | Add 26.72% | 6,346 | $68.49 |
| Q2 2024 | -231 | Reduce 3.64% | 6,115 | $77.01 |
| Q3 2024 | +1,840 | Add 30.09% | 7,955 | $83.80 |
| Q4 2024 | +3,475 | Add 43.68% | 11,430 | $89.32 |
| Q1 2025 | +23,542 | Add 205.97% | 34,972 | $100.88 |
| Q2 2025 | +39,545 | Add 113.08% | 74,517 | $107.41 |
| Q3 2025 | +126,595 | Add 169.89% | 201,112 | $97.63 |
Joel Greenblatt's Boston Scientific Corporation Investment FAQs
Joel Greenblatt first purchased Boston Scientific Corporation (BSX) in Q2 2013, acquiring 60,894 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Boston Scientific Corporation (BSX) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's largest addition to Boston Scientific Corporation (BSX) was in Q1 2017, adding 1,664,082 shares worth $41.39 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 201,112 shares of Boston Scientific Corporation (BSX), valued at approximately $19.63 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Boston Scientific Corporation (BSX) represents approximately 0.09% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's peak holding in Boston Scientific Corporation (BSX) was 1,664,082 shares, as reported at the end of Q1 2017. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.